Percutaneous Tracheostomy With Aerosol Box in COVID-19 Positive Patients in Intensive Care Unit: a Clinical Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Tracheostomy
- Sponsor
- Çanakkale Onsekiz Mart University
- Enrollment
- 24
- Locations
- 1
- Primary Endpoint
- Complications observed in the cases in which we applied percutaneous tracheostomy with aerosol box
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
Coronavirus disease 2019 (COVID-19) has brought about a requirement of intensive care and mechanical ventilation for a significant portion of patients. Percutaneous tracheostomy is performed in order to reduce the complications that may develop due to prolonged endotracheal intubation.
Detailed Description
Different methods are needed for situations in which the potential for producing aerosols is high, such as intubation and tracheostomy. One of these methods is the aerosol box.To share our experiences of percutaneous tracheostomy performed with aerosol box in COVID-19 patients. Patients who underwent percutaneous tracheostomy between March 2020 and June 2020 in the pandemic intensive care unit were evaluated retrospectively.The study is designed as a clinical trial study. This study was performed in faculty of medicine hospital's intensive care unit which is located in Canakkale province Turkey.
Investigators
Mesut ERBAS
Associate Professor
Çanakkale Onsekiz Mart University
Eligibility Criteria
Inclusion Criteria
- •who underwent percutaneous tracheostomy with COVID-19(+)
Exclusion Criteria
- •Patients who do not give informed consent or do not want to participate in the study
- •Coagulopathy, thrombocytopenia
Outcomes
Primary Outcomes
Complications observed in the cases in which we applied percutaneous tracheostomy with aerosol box
Time Frame: During the procedure
Complications